Pentoxifylline NEW
| Price | $40 |
| Package | 500mg |
| Supply Ability: | 10g |
| Update Time: | 2026-07-27 |
Product Details
| Product Name: Pentoxifylline | CAS No.: 6493-05-6 |
| Purity: 99.96% | Supply Ability: 10g |
| Release date: 2026/07/27 |
Product Introduction
Bioactivity
| Name | Pentoxifylline |
| Description | Pentoxifylline (PTX) modulates immunologic activity by stimulating cytokine production. Pentoxifylline is a methylxanthine derivative that inhibits phosphodiesterase and affects blood rheology. It also inhibits platelet aggregation and improves blood flow by increasing erythrocyte and leukocyte flexibility. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | H2O : 50.8 mg/mL (182.53 mM), Sonication is recommended. 10% DMSO+90% Saline : 4.9 mg/mL (17.61 mM), Solution. DMSO : 49 mg/mL (176.06 mM), Sonication is recommended. |
| Keywords | venous | vasculopathies | vasculitides | ulcers | purpuric | pigmented | Phosphodiesterase (PDE) | phosphodiesterase | peripheral vascular | Pentoxifylline | PDE | methyl-xanthine | leprosy | leg | intermittent | Inhibitor | inhibit | immunomodulator | Human immunodeficiency virus | HIVProtease | HIV Protease | HIV | hemorrheologic | hemorheological | diseases | dermatoses | dermatological | claudication | BL191 | BL 191 | Autophagy | anti-hypercholesterolemic | AdenosineReceptor | Adenosine Receptor | A2 |
| Inhibitors Related | Stavudine | Aceglutamide | Hemin | Emtricitabine | D(+)-Raffinose pentahydrate | Guanidine hydrochloride | Hydroxychloroquine | Lamivudine | Paeonol | Naringin | Alginic acid | Dextran sulfate sodium salt (MW 5000) |
| Related Compound Libraries | Anti-Neurodegenerative Disease Compound Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Anti-Viral Compound Library | Inhibitor Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Anti-Aging Compound Library | Bitter Compound library | GPCR Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $40.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2026-07-27 | |
| $40.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-07-27 | |
|
VIP6Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2026-07-27 | ||
| $1.00 |
VIP7Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2020-05-12 | |
| $7.00 |
VIP9Y
|
Career Henan Chemical Co
|
2019-07-06 | |
| $40.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2025-05-02 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY